1. |
2017/03/21 |
私のキャリア形成(東京)
|
2. |
2016/11/05 |
自然炎症の破綻と癌転移(東京, 日本)
|
3. |
2016/10/24 |
炎症とがん転移(東京, 日本)
|
4. |
2016/03/24 |
転移なければ虎も猫(東京, 日本)
|
5. |
2014/12 |
Inflammation and metastatic microenvironment.(京都, 日本)
|
6. |
2014/10/30 |
How pre-metastatic soil is established
|
7. |
2013/06 |
How premetastatic milieu is established.
|
8. |
2013/06 |
S100A8 and lung metastasis.
|
9. |
2013/06 |
The endogenous TLR4 ligand-mediated vaso-permeability is required for lung metastasis.
|
10. |
2012/04 |
S100A8, amyloid A3, and TLR4 in tumor metastasis.
|
11. |
2011/10 |
新概念「自然炎症」で転移の「病気標的薬」を模索する(東京, 日本)
|
12. |
2011/09 |
Dysregulated lung homeostasis involving the TLR4-SAA3 system establishes lung metastasis.
|
13. |
2011/09 |
Dysregulated lung homeostasis involving the TLR4-SAA3 system in Clara cells and Eph-ephrin signaling establishes lung metastasis.
|
14. |
2011/09 |
Regulation of mature versus immature conformation of BCR-ABL.
|
15. |
2011/06 |
Homeostatic regulation of endotoxin response by endogenous TLR4 ligands is hijacked by metastatic tumor cells.
|
16. |
2011/06 |
転移前微小環境とは(東京, 日本)
|
17. |
2010/09 |
Mutator phenotype of BCR-ABL.(Washington DC, USA)
|
18. |
2010/06 |
EphA1/ephrinA1 at the Intersection of TLR4/TNFR Signaling.(Winston-Salem, NC, USA)
|
19. |
2009/10 |
The endogenous TLR4 ligands regulate pre-metastatic soil.(Osaka.)
|
20. |
2009/09 |
CHIP works with Hsc70 co-chaperone ro degrade BCR-ABL.(Bordeaux, France.)
|
21. |
2009/09 |
Strategies to cope with drug resistance in taxanes and imatinib.(Hamburg, Germany.)
|
22. |
2009/09 |
The endogenous TLR4 ligands regulate pre-metastatic soil.(Kloster Seeon, Germany.)
|
23. |
2009/08 |
転移前土壌(御殿場, 日本)
|
24. |
2009/06 |
Ephの構造と機能—EphA1を中心に(和歌山, 日本)
|
25. |
2009/06 |
How organ-specific pre-metastatic soil is prepared.(Helsinki, Finland.)
|
26. |
2008/10 |
Endothelial growth factor receptor 1 initiates endogenous ligand-induced activation of pathogen sensor in pre-metastatic phase.(Rochester, USA Travel award from Mrs. O’Connor.)
|
27. |
2008/10 |
優れた分子標的薬は病気標的薬である(横浜, 日本)
|
28. |
2008/03 |
がん薬物治療における分子標的治療薬の基礎研究の重要性(東京, 日本)
|
29. |
2007/10 |
がんにおけるハイジャック仮説(福島, 日本)
|
30. |
2007/06 |
癌を抑制する新しい作用点の模索 特別企画「基礎からみた癌治療」(東京, 日本)
|
5件表示
|
全件表示(30件)
|